Hodgkin's Disease News and Research

RSS
Hodgkin's disease, (Thomas Hodgkin, 1798 - 1866, English physician), is separated from the more common and more frequently fatal non Hodgkins lymphoma, by the presence of a distinctive histological feature, the Sternberg - Reed giant cell, a large reticulum cell with a tendency to form large, densely staining nuclei.
U.S. clinical trials provide further evidence of importance of storing umbilical cord blood

U.S. clinical trials provide further evidence of importance of storing umbilical cord blood

BGU Professor awarded grant to develop target-specific, anti-cancer drugs

BGU Professor awarded grant to develop target-specific, anti-cancer drugs

LLS collaborates with Shape Pharmaceuticals to advance treatment for CTCL

LLS collaborates with Shape Pharmaceuticals to advance treatment for CTCL

Wyse Technology announces partnership, continued success with LLS

Wyse Technology announces partnership, continued success with LLS

LLS awards two new grants through prestigious Marshall A. Lichtman SCOR research initiative

LLS awards two new grants through prestigious Marshall A. Lichtman SCOR research initiative

Free education program highlights advancements in treatment of blood cancers, importance of clinical trials

Free education program highlights advancements in treatment of blood cancers, importance of clinical trials

Hana Biosciences reports complete data from Marqibo Phase 2 RALLY trial for relapsed/refractory adult ALL

Hana Biosciences reports complete data from Marqibo Phase 2 RALLY trial for relapsed/refractory adult ALL

LLS's School & Youth Programs raise $1M to help fight against childhood cancer

LLS's School & Youth Programs raise $1M to help fight against childhood cancer

Hana Biosciences announces completion of Marqibo pre-NDA meeting with FDA

Hana Biosciences announces completion of Marqibo pre-NDA meeting with FDA

Data from pivotal study of Marqibo in ALL patients to be presented at ASCO meeting

Data from pivotal study of Marqibo in ALL patients to be presented at ASCO meeting

Rebirth of the cursed drug Thalidomide

Rebirth of the cursed drug Thalidomide

Aprepitant drug can reduce nausea and vomiting when combined with other anti-nausea drugs

Aprepitant drug can reduce nausea and vomiting when combined with other anti-nausea drugs

LLS increases maximum benefit for myeloma patients to $10,000

LLS increases maximum benefit for myeloma patients to $10,000

Students collect money to support vital cancer research initiatives

Students collect money to support vital cancer research initiatives

Bone marrow transplantation survivors can father children: new study says

Bone marrow transplantation survivors can father children: new study says

4SC commences treatment in its resminostat Phase II trial for HL

4SC commences treatment in its resminostat Phase II trial for HL

Preclinical and Phase I data for TG-0054 presented by TaiGen Biotechnology

Preclinical and Phase I data for TG-0054 presented by TaiGen Biotechnology

New analyses of data from Allos Therapeutics’ pivotal PROPEL trial of FOLOTYN reported

New analyses of data from Allos Therapeutics’ pivotal PROPEL trial of FOLOTYN reported

Fight 2 Win PSA launched to find a cure for Hodgkin's Disease

Fight 2 Win PSA launched to find a cure for Hodgkin's Disease

Medical care in Germany for children with cancer is very good: IQWiG report

Medical care in Germany for children with cancer is very good: IQWiG report